WebMedical - Drug Manufacturing. $0.576B. $0.053B. CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe, and on … WebCTIC Stock 12 Months Forecast. Based on 7 Wall Street analysts offering 12 month price targets for CTI BioPharma in the last 3 months. The average price target is $11.30 with a high forecast of $15.00 and a low forecast of $8.10. The average price target represents a 167.14% change from the last price of $4.23.
CTI BioPharma Corp. (CTIC) Stock Forecast & Price Targets - Stock …
Web2 days ago · SEATTLE, Wash., April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that the management team will participate in two upcoming investor … WebCTIC : 4.09 (-0.24%) CTI BioPharma to Participate in Upcoming Investor Conferences in February 2024 PR Newswire - Thu Feb 2, 6:00AM CST. /PRNewswire/ -- CTI BioPharma … fitzgerald last tycoon gutenberg
CTI BioPharma Corp. (CTIC) Stock Chart - Stock Analysis
Web28 rows · Historical daily share price chart and data for CTI BioPharma since 1997 … Web20 hours ago · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator ... WebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you … can i henna over dyed hair